Skip to content

PLLACUBE® is available exclusively to registered clinic accounts — Apply for access

PLLACUBE® TECHNOLOGY — OFFICIAL CANADA & U.S. DISTRIBUTOR

Give Your Clients Korea's Most
Advanced Skinbooster

PLLACUBE® is Korea's 5th-generation skinbooster — combining PLLA, PDRN, Vitamin C, Glutathione, and Hyaluronic Acid in one stabilized formula, powered by patented InCube™ Technology. Now available exclusively for registered clinics across North America.

Health Canada Registered FDA Cosmetic Listed Clinically Evaluated in Korea Patent No. 10-2488551

PLLA · PDRN · Glutathione · Vitamin C · Plant-Derived Exosomes · Hyaluronic Acid

Developed by Lab InCube Co., Ltd. — Korean biomaterial R&D · Advanced Material Science · Applied Biotechnology

PLLACUBE Original Vial

What is PLLACUBE?

Six Clinically Proven Actives.
One Stabilized System.

PLLACUBE® is a next-generation skinbooster combining Poly-L-Lactic Acid (PLLA), PDRN, Vitamin C, Glutathione, Houttuynia Cordata Extract, and Hyaluronic Acid — formulated to deliver both regenerative and brightening effects in a single professional-use vial.

Vitamin C and Glutathione — both highly susceptible to oxidation — are stabilized through the InCube™ Protection Platform developed by Lab InCube Co., Ltd.

C — Selective Encapsulation P — Environmental Protection R — Optimized Release

Protected by international patent No. 10-2488551, InCube™ ensures maximum ingredient stability, controlled release, and consistent performance in every vial.

Learn More about LabInCube →

Formulation Science

Key Ingredients of PLLACUBE® Original — All in One

Formulated with PLLA, PDRN, Vitamin C, Glutathione, Houttuynia Cordata Extract, and Hyaluronic Acid, PLLACUBE® Original offers a next-generation approach to professional skin revitalization. This synergistic combination is designed to help improve the appearance of firmness, clarity, and overall skin quality — supporting a smoother and more radiant complexion after treatment.

Among the actives, Vitamin C and Glutathione are safeguarded through the InCube™ stabilization platform, which helps maintain ingredient freshness and minimize oxidation during formulation, ensuring consistent quality in every vial.

PLLACUBE Original Key Ingredients Diagram

InCube™ C·P·R Technology (Capsulation · Protection · Release) is a patented biomaterial stabilization system from Lab InCube Co., Ltd., ensuring superior stability and sustained ingredient performance.

Clinical Evidence

Clinical Results of PLLACUBE® Original

Clinically evaluated by the Human Skin Clinical Testing Center (2024), PLLACUBE® demonstrated significant improvements across multiple parameters including hydration, elasticity, skin tone, and texture refinement — confirming its performance for professional clinical use.

48.95%

Surface Skin Hydration

13.04%

Pore Refinement

3 Weeks

Observable Results

33

Study Participants

PLLACUBE Clinical Results - 48.95% Improvement in Hydration
PLLACUBE Original Before and After Clinical Study Results

Study period: Jul. 23–Jul. 25, 2024 · Participants: 33 · Study No.: HM-P24-0335 · Testing Center: Human Skin Clinical Testing Center, Korea

For Licensed Clinics & Medspas

Ready to offer these results to your clients?

Wholesale pricing and full ordering access are available exclusively to registered clinic accounts. Apply and get approved within 1–2 business days.

Apply for Clinic Access

No minimum order commitment  ·  Health Canada registered  ·  FDA cosmetic listed

Particle Engineering

Advanced PLLA Particle Technology

Precision-engineered PLLA particles are carefully designed into a spherical shape, promoting smooth application and even distribution. The uniform particle size of 30–80 µm enhances product consistency and performance, contributing to a refined, professional-grade skincare experience.

Conventional PLLA particles with irregular, jagged shapes Conventional
Conventional PLLA
Irregular particle morphology may lead to uneven spread and inconsistent texture.
Jagged/irregular edges Variable particle size distribution
LABINCUBE PLLA particles with uniform spherical shape LABINCUBE PLLA 30–80 µm
Uniform, Near-Spherical PLLA
Consistent, near-spherical morphology supports smoother application and even distribution.
Controlled size distribution (30–80 µm) Refined texture & consistent spread

Micrograph images are illustrative to highlight particle morphology differences.

FAQ

Professional Treatment Protocol

Access our comprehensive guide for using PLLACUBE with microneedling, RF treatments, and post-laser care protocols.

View Protocol Guide

Scientific Foundation

The Research Behind the Results

PLLACUBE's InCube™ Technology is not just patented — it's grounded in Nobel Prize-recognized molecular science, with peer-reviewed publications in leading international journals and co-authored research with Seoul National University Hospital.

2025 Nobel Prize in Chemistry

InCube™ is built on MOF science awarded the Nobel Prize. LabInCube's founder trained under Prof. Omar Yaghi at UC Berkeley — the Nobel laureate who pioneered MOF research.

Seoul National University Hospital

LabInCube co-authored peer-reviewed skin research with SNUH Bundang — Korea's most prestigious academic medical center — validating MOF technology in skin applications.

GCP-Certified Clinical Study

3-week study at Human Co., Ltd. Skin Clinical Trial Center, Korea. Statistically significant improvements across 5 skin parameters (p<0.001 vs. baseline).

5 Registered Patents

Protected by 5 Korean IP Office patents including Patent No. 10-2488551. Multi-porous encapsulation engineered for ingredient stability and controlled release.

Advanced Healthcare Materials · Wiley · 2023

Zirconium-Based MOF Capable of Binding Proinflammatory Mediators Promotes Wound Healing Through a Multiscale Adsorption Mechanism

Institutions: Sookmyung Women's University · Seoul National University Bundang Hospital · LabInCube Co., Ltd.
DOI: 10.1002/adhm.202301679

In Vivo · 2024

Effect of Silicone Patch Containing Metal-Organic Framework on Hypertrophic Scar Suppression

Institutions: Seoul National University Hospital · Seoul National University College of Medicine · LabInCube Co., Ltd.
DOI: 10.21873/invivo.13430

Wholesale access for licensed clinics Apply for Clinic Access